Insider NameBuy/SellCompany NameTickerAmountShares Change
Sep 15, 2020Sep 16, 2020Duncan Barbara Gayle
Dir
SellJounce Therapeutics, Inc.JNCE$10$100,000-0
Mar 15, 2018Mar 19, 2018Duncan Barbara Gayle
Dir
SellJounce Therapeutics, Inc.JNCE$28.11$56,220-0
Jan 26, 2018Jan 30, 2018Duncan Barbara Gayle
Dir
SellJounce Therapeutics, Inc.JNCE$25$100,000-0
Oct 17, 2017Oct 18, 2017Duncan Barbara Gayle
Dir
BuyAevi Genomic Medicine, Inc.GNMX$1.26$75,000+50.00%
Oct 03, 2016Oct 06, 2016Duncan Barbara Gayle
Chief Accounting Officer
SellIntercept Pharmaceuticals IncICPT$163.2$23,990-0.48%
Jul 05, 2016Jul 08, 2016Duncan Barbara Gayle
Chief Accounting Officer
SellIntercept Pharmaceuticals IncICPT$145.11$21,186-0.47%
Apr 04, 2016Apr 07, 2016Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$130.76$18,829-0.46%
Jan 04, 2016Jan 06, 2016Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$145.9$68,283-1.85%
Oct 01, 2015Oct 06, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$163.17$171,978-4.20%
Jul 02, 2015Jul 08, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$236.26$12,522-0.28%
Jul 01, 2015Jul 07, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$242.1$242,100-5.40%
Apr 02, 2015Apr 04, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$277.7$10,830-0.22%
Mar 27, 2015Apr 01, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$289.82$289,817-5.79%
Jan 05, 2015Jan 08, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$176.49$24,884-0.81%
Jan 02, 2015Jan 06, 2015Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$156.4$156,400-5.43%
Oct 01, 2014Oct 04, 2014Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$233.12$233,119-5.85%
Apr 14, 2014Apr 16, 2014Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$279$321,966-7.87%
Jan 15, 2014Jan 18, 2014Duncan Barbara Gayle
CFO
SellIntercept Pharmaceuticals IncICPT$259.19$1M-34.44%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.